Article Details

China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of ... - BioSpace

Retrieved on: 2025-03-14 13:51:45

Tags for this article:

Click the tags to see associated articles and topics

China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of ... - BioSpace. View article details on hiswai:

Summary

The article discusses the approval of SYCUME® (teprotumumab), a groundbreaking IGF-1R antibody for thyroid eye disease (TED), reflecting advancements in autoimmune disease treatment and epidemiology by Innovent Biologics in collaboration with Eli Lilly. The development addresses unmet needs in TED, primarily impacting those with thyroid-related conditions.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up